Literature DB >> 685737

A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism.

L Mosekilde, F Melsen.   

Abstract

Increased bone, resorption previously found in hyperthyroidism might be caused by a direct stimulating effect of thyroid hormone(s) on bone cells or by an increased sensitivity to circulating parathyroid hormone. In order to disclose qualitative differences in the response of bone resorbing cells to excess parathyroid hormone and excess thyroid hormone(s), histomorphometric analysis of iliac crest biopsies was performed in 25 hyperparathyroid and 40 hyperthyroid patients after tetracycline double-labelling. The main target cells for parathyroid and thyroid hormones were different. Parathyroid hormone stimulated osteocytic osteolysis and increased osteoclastic resorption surfaces equally in trabecular and cortical bone. The osteoclastic resorption was inactive. Thyroid hormone(s) had no effect on osteocytes but increased the osteoclastic resorption surfaces in trabecular and cortical bone, with a pronounced preponderance in cortical bone. The osteoclastic resorption was active and followed by a significant loss of both cortical and trabecular bone. The findings support the assumption that increased bone resorption in hyperthyroidism is caused by a direct stimulating effect of thyroid hormone(s).

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 685737     DOI: 10.1111/j.0954-6820.1978.tb08406.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  21 in total

1.  Bone histomorphometry and serum bone gla-protein in the diagnosis of primary hyperparathyroidism.

Authors:  P D Delmas; P J Meunier; E Faysse; E C Saubier
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

2.  Hormonal Regulation of Osteocyte Perilacunar and Canalicular Remodeling in the Hyp Mouse Model of X-Linked Hypophosphatemia.

Authors:  Danielle Tokarz; Janaina S Martins; Elizabeth T Petit; Charles P Lin; Marie B Demay; Eva S Liu
Journal:  J Bone Miner Res       Date:  2017-11-17       Impact factor: 6.741

3.  Evaluation of cortical bone mass, thickness and density by z-scores in osteopenic conditions and in relation to menopause and estrogen treatment.

Authors:  S Meema; H E Meema
Journal:  Skeletal Radiol       Date:  1982       Impact factor: 2.199

4.  Osteocytic Osteolysis in PTH-treated Wild-type and Rankl-/- Mice Examined by Transmission Electron Microscopy, Atomic Force Microscopy, and Isotope Microscopy.

Authors:  Hiromi Hongo; Tomoka Hasegawa; Masami Saito; Kanako Tsuboi; Tomomaya Yamamoto; Muneteru Sasaki; Miki Abe; Paulo Henrique Luiz de Freitas; Hisayoshi Yurimoto; Nobuyuki Udagawa; Minqi Li; Norio Amizuka
Journal:  J Histochem Cytochem       Date:  2020-09-18       Impact factor: 2.479

5.  A prospective study of thyroid function, bone loss, and fractures in older men: The MrOS study.

Authors:  Avantika C Waring; Stephanie Harrison; Howard A Fink; Mary H Samuels; Peggy M Cawthon; Joseph M Zmuda; Eric S Orwoll; Douglas C Bauer
Journal:  J Bone Miner Res       Date:  2013-03       Impact factor: 6.741

Review 6.  Vitamin E management of oxidative damage-linked dysfunctions of hyperthyroid tissues.

Authors:  Paola Venditti; Lisa Di Stefano; Sergio Di Meo
Journal:  Cell Mol Life Sci       Date:  2012-12-20       Impact factor: 9.261

Review 7.  Osteocytes remove and replace perilacunar mineral during reproductive cycles.

Authors:  John J Wysolmerski
Journal:  Bone       Date:  2013-01-23       Impact factor: 4.398

8.  Trabecular bone microarchitecture in mild primary hyperparathyroidism.

Authors:  L Dalle Carbonare; P Ballanti; F Bertoldo; M T Valenti; B Giovanazzi; S Giannini; G Realdi; V Lo Cascio
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

Review 9.  Bone physiology, disease and treatment: towards disease system analysis in osteoporosis.

Authors:  Teun M Post; Serge C L M Cremers; Thomas Kerbusch; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

10.  Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry.

Authors:  P D Delmas; B Demiaux; L Malaval; M C Chapuy; C Edouard; P J Meunier
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.